These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 10942956)

  • 21. Recurrent adenocarcinoma of prostate presenting as acquired haemophilia A.
    Sati HI; Watson HG
    Thromb Haemost; 1998 Dec; 80(6):1034. PubMed ID: 9869184
    [No Abstract]   [Full Text] [Related]  

  • 22. Successful use of mycophenolate mofetil and prednisone in a 14-year-old girl with acquired hemophilia A.
    Eisert S; Mosler K; Laws HJ; Göbel U
    Thromb Haemost; 2005 Apr; 93(4):792-3. PubMed ID: 15841330
    [No Abstract]   [Full Text] [Related]  

  • 23. [Acquired haemophilia A: two cases].
    de Vitry A; Valois A; Weinborn M; Dupuy-de Fonclare AL; Cuny JF; Barbaud A; Schmutz JL
    Ann Dermatol Venereol; 2014; 141(6-7):441-5. PubMed ID: 24951143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acquired hemophilia A: a review of recent data and new therapeutic options.
    Franchini M; Vaglio S; Marano G; Mengoli C; Gentili S; Pupella S; Liumbruno GM
    Hematology; 2017 Oct; 22(9):514-520. PubMed ID: 28441921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current management of acquired factor VIII inhibitors.
    Barnett B; Kruse-Jarres R; Leissinger CA
    Curr Opin Hematol; 2008 Sep; 15(5):451-5. PubMed ID: 18695367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of an acquired factor VIII inhibitor and plasmapheresis therapy in a patient with bullous pemphigoid.
    Zhang GS; Zuo WL; Dai CW; Xu YX; Shen JK; Luo YY; Yi Y
    Thromb Haemost; 2006 Nov; 96(5):692-4. PubMed ID: 17080230
    [No Abstract]   [Full Text] [Related]  

  • 27. Hemostasis in acquired hemophilia--role of intracavitary instillation of EACA.
    Sahu S; Raipancholia R; Pardiwalla FK; Pathare AV
    J Postgrad Med; 1996; 42(3):88-90. PubMed ID: 9715327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rituximab for the treatment of patients with very high-titre acquired factor VIII inhibitors refractory to conventional chemotherapy.
    Field JJ; Fenske TS; Blinder MA
    Haemophilia; 2007 Jan; 13(1):46-50. PubMed ID: 17212724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acquired hemophilia and its treatment.
    Sultan Y
    Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S15-8. PubMed ID: 9351531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical heterogeneity of acquired hemophilia A: a description of 4 cases.
    Franchini M; Girelli D; Olivieri O; Bozzini C; Guiotto M; Zardini G; Lippi G; Manzato F; Gandin G
    Haematologica; 2005 Mar; 90(3):ECR16. PubMed ID: 15753057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acquired hemophilia: diagnosis and management.
    Zakarija A; Green D
    Curr Hematol Rep; 2002 Sep; 1(1):27-33. PubMed ID: 12901122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acquired hemophilia: a case report of 2 patients with acquired factor VIII inhibitor treated with rituximab plus a short course of steroid and review of the literature.
    Alvarado Y; Yao X; Jumper C; Hardwicke F; D'Cunha N; Cobos E
    Clin Appl Thromb Hemost; 2007 Oct; 13(4):443-8. PubMed ID: 17911199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-titer acquired factor V inhibitor responsive to corticosteroids and cyclophosphamide in a patient with two malignant tumors.
    Bayani N; Rugina M; Haddad-Vergnes L; Lelong F
    Am J Hematol; 2002 Sep; 71(1):33-6. PubMed ID: 12221671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cyclosporine A as an effective treatment for a patient with acquired hemophilia A complicated with diabetes mellitus and ischemic heart disease].
    Wano Y; Kang Y; Masaki H; Kawabata H; Fukushima T; Shimoyama K; Satoh A; Miyairi Y; Kashiwaba M; Hirose Y
    Rinsho Ketsueki; 2005 Oct; 46(10):1100-4. PubMed ID: 16440770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunosuppression of patients with acquired factor VIII inhibitors.
    Green D
    Semin Hematol; 1994 Apr; 31(2 Suppl 4):60-1. PubMed ID: 7939780
    [No Abstract]   [Full Text] [Related]  

  • 36. Cholecystectomy and acquired factor VIII inhibitor coagulopathy.
    Walsh JD; Landercasper J; Bottner WA; Boyd WC
    Am Surg; 2004 Sep; 70(9):815-7. PubMed ID: 15481301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Anti-factor VIII antibodies in children with hemophilia, and the management of hemorrhage].
    Klukowska A; Adamowicz-Salach A; Kamińska D; Zieleniewska B
    Pol Tyg Lek; 1987 Jul; 42(30):911-4. PubMed ID: 3118341
    [No Abstract]   [Full Text] [Related]  

  • 38. Factor VIII-hydrolyzing IgG in acquired and congenital hemophilia.
    Wootla B; Mahendra A; Dimitrov JD; Friboulet A; Borel-Derlon A; Rao DN; Uda T; Borg JY; Bayry J; Kaveri SV; Lacroix-Desmazes S
    FEBS Lett; 2009 Aug; 583(15):2565-72. PubMed ID: 19595998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A prospective, randomized trial of prednisone and cyclophosphamide in the treatment of patients with factor VIII autoantibodies.
    Green D; Rademaker AW; Briët E
    Thromb Haemost; 1993 Nov; 70(5):753-7. PubMed ID: 8128430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant FVIIa in the treatment of bleeding in acquired hemophilia.
    Guerin V; Chossat I; Dutronc H; Dubreuil M; Valentin F
    Am J Hematol; 2002 Aug; 70(4):333. PubMed ID: 12210820
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.